In colorectal cancer, the discussion will focus on KRAS, BRAF; carcinoembryonic antigen (CEA); and novel biomarkers such as circulating tumor DNA (ctDNA), methylated SEPT9, and selected microRNAs. This evidence concerns the gene CEACAM5 and neoplasm.